BCPC - Balchem: A Tale Of Two Businesses

2024-05-10 04:54:04 ET

Summary

• Balchem Corporation's Q1 2024 earnings surpassed expectations, but the company's full-year bottom-line expansion could be slower than what it achieved for the first quarter.
• The Human Nutrition & Health segment is riding on the supplements market's growth, while the Animal Nutrition & Health segment is encountering stiff competition in the European animal feed market.
• It is a tale of two businesses for BCPC, which implies that the stock warrants a Neutral or Hold rating.

Elevator Pitch

I award a Hold investment rating to Balchem Corporation ( BCPC ). My earlier update written on February 21, 2024 reviewed the company's Q4 2023 results....

For further details see: